Stem Cell & Regenerative Medicine

3D Bioprinting, Organ Fabrication & Bioartificial Tissues

3D bioprinting represents a transformative approach in regenerative medicine, allowing precise fabrication of living tissues and organ constructs. Using patient-specific cells, bioinks, and scaffold materials, researchers can design complex tissue architectures that mimic native organ structures and functions. Advances in bioprinting technology have enabled the production of vascularized tissues, multi-layered organoids, and functional microtissues suitable for transplantation and disease modeling. Bioartificial tissues provide platforms for drug testing, toxicology studies, and personalized therapeutics, reducing reliance on animal models. Integration of stem cells and growth factors enhances tissue maturation, cellular organization, and regenerative potential. Current research focuses on improving printing resolution, ensuring cell viability, and establishing scalable, reproducible manufacturing processes for clinical translation. Bioprinted constructs are being explored for cardiac patches, liver tissue, cartilage repair, and skin regeneration. Challenges include vascularization, immunocompatibility, mechanical stability, and regulatory approvals. This session covers cutting-edge developments, including multi-material bioprinting, organ-on-chip integration, and hybrid biomaterial design, providing attendees with insights into how 3D bioprinting is shaping the future of organ fabrication and personalized regenerative therapies.